Press-release for stocks publishing date 2021 - 12

Prices are updated after-hours

| 18.93% | O: -1.1% H: 0.0% C: 0.0%
conference phase 1 bioscience

| -85.29% | O: 4.28% H: 0.0% C: 0.0%
conference bioscience

| -75.17% | O: -1.39% H: 0.0% C: 0.0%
treatment phase 2 trial bioscience ulcerative colitis

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
YTEN | $0.252 -7.59% -8.21% 280K

| -93.6% | O: 0.25% H: 0.0% C: 0.0%
conference bioscience

Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer
Published: 2021-12-06 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

| -3.51% | O: -4.23% H: 0.11% C: 0.11%
ENVB | $0.8989 -4.17% -4.35% 130K

| -26.97% | O: -13.69% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -2.44% | O: 0.02% H: 0.0% C: 0.0%
bioscience

Castle Biosciences Completes Acquisition of Cernostics
Published: 2021-12-06 (Crawled : 13:00) - biospace.com/
CSTL | $19.28 0.42% 0.41% 130K

| -53.8% | O: -1.42% H: 0.0% C: 0.0%
acquisition bioscience

Bright Minds Biosciences to Present at the Stifel GMP 2nd Annual Future of Healthcare Conference
Published: 2021-12-06 (Crawled : 09:00) - brightmindsbio.com
DRUG | $1.25 -6.61% 11K

| -68.21% | O: 1.03% H: 0.0% C: 0.0%
thc conference bioscience

67%

33%

Save your searches and get alerts when important news are released.